Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer

Jiangyong Yu, Shuhang Wang, Wei Zhao, +10

Clinical Cancer Research

The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients

Minglei Zhuo, Hanxiao Chen, Tianzhuo Zhang, +8

Cancer Biomarkers

A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

Bo Jia, Qiwen Zheng, Jingjing Wang, +13

BMC Cancer

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

Jia Zhong, Zihan Guo, Liping Fan, +16

Thoracic Cancer

Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database

Yuyan Wang, Qiwen Zheng, Bo Jia, +14

Frontiers in Oncology

Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification

Bo Jia, Xinghui Zhao, Di Wu, +23

Translational Lung Cancer Research

Nomogram to predict cause‐specific mortality in extensive‐stage small cell lung cancer: A competing risk analysis

Jia Zhong, Qiwen Zheng, Tongtong An, +14

Thoracic Cancer

The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer

Hanxiao Chen, Dingzhi Huang, Gen Lin, +12

Cancer Medicine

Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small cell lung cancer: A real-world, multicenter, retrospective, controlled study in China

Hanxiao Chen, Xiangjuan Ma, Jie Liu, +6

Chinese Journal of Cancer Research

Survival comparison of right and left side non‐small cell lung cancer in stage I–IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis

Bo Jia, Qiwen Zheng, Xinmeng Qi, +17

Thoracic Cancer